Cargando…
A Double-Blind, Randomised, Crossover Trial of Two Botulinum Toxin Type A in Patients with Spasticity
BACKGROUND: Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new released botulinum toxin serotype A may have the same effectiveness as Botox® in focal dystonia. However, there are no randomized clinical trials comparing these formulations...
Autores principales: | Guarany, Fábio Coelho, Picon, Paulo Dornelles, Guarany, Nicole Ruas, dos Santos, Antonio Cardoso, Chiella, Bianca Paula Mentz, Barone, Carolina Rocha, Fendt, Lúcia Costa Cabral, Schestatsky, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585303/ https://www.ncbi.nlm.nih.gov/pubmed/23468866 http://dx.doi.org/10.1371/journal.pone.0056479 |
Ejemplares similares
-
The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021) -
Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity
por: Rekand, Tiina, et al.
Publicado: (2019) -
Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011) -
The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia
por: Chen, Yen-Ting, et al.
Publicado: (2020) -
Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)